Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01707264
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : August 28, 2018
Sponsor:
Information provided by (Responsible Party):
Prothena Therapeutics Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 9, 2016
Actual Study Completion Date : August 9, 2016
Certification/Extension First Submitted : November 20, 2017